Admedus Immunotherapies

Learn More


Admedus Tissue Engineering

Learn More


Admedus Medical Products

Learn More

Welcome to Admedus

We are a diversified healthcare group that is developing, investing in and delivering a range of exciting new technologies and leading edge medical devices that have the potential to make a real difference to the outcomes and quality of life of patients around the globe.

Learn More

News & Media

< >
The Australian Logo

Admedus HSV-2 clinical results encouraging – Morgans

Morgans healthcare analyst Scott Power talks to The Australian about Admedus’s HSV-2 Phase II clinical trial results.

March 7th 2016

Find out more
Ian Frazer

Gardasil creator is testing a DNA vaccine to wipe out cancer-causing HPV virus

Professor Ian Frazer (the creator of Gardasil) is working with healthcare company Admedus to create a DNA vaccine which could be injected in people who already have HPV to stop it progressing to cervical cancer. Admedus Chief Scientific Officer Dr David Rhodes said the technology developed by Admedus in conjunction with Frazer could potentially be applied to a […]

March 3rd 2016

Find out more

Open Letter From Mr Wayne Paterson To Shareholders

Dear Shareholders and friends of Admedus, I would like to take the opportunity to update you on current events and what you can expect from the team moving forward.

February 10th 2016

Find out more

Admedus inks exclusive distro deal with Coroneo

Admedus (ASX:AHZ) has inked an exclusive distribution agreement with Coroneo to sell its extra aortic annuloplasty ring and other heart valve surgery instruments in Germany and the U.K.

January 27th 2016

Find out more
Cardiovascular News

CardioCel bio-scaffold launched and sold in Malaysia

CardioCel has now been launched in Malaysia and the Company has achieved its first sales in the country. Click here to read the full article  

November 4th 2015

Find out more

Upcoming Events

No Upcoming Events